Deion Sanders says he had bladder cancer but will coach the Colorado Buffaloes this season
Dr. Janet Kukreja, the director of urologic oncology at the CU Cancer Center/UCHealth University of Colorado hospital, said Sanders had his bladder removed as part of the surgical plan.
'It was dynamic. It was tough. It wasn't a cakewalk. It wasn't easy,' said Sanders, who arrived to his news conference wearing a cowboy hat and overalls along with sunglasses, which he took off after getting choked up. 'That was a fight, but we made it.'
Sanders, who turns 58 next month, spoke on the eve of fall camp as he enters his third season overseeing the Buffaloes. He brought his medical team with him to discuss his diagnosis. A section of his intestine was reconstructed to function as a bladder.
Sanders said he lost about 25 pounds, leading him to joke, 'I was like Atlanta Falcons Prime at one point.'
He remained upbeat through the entire ordeal.
'He never folded one time and never wavered,' team trainer Lauren Askevold said. 'You couldn't ask for a better patient because he wants to get up and get going right. So it's been awesome. It's been a hectic journey, but there's a blessing very in disguise with all this.'
The charismatic coach returned to campus last week and announced on social media, 'Back and Feeling Great!' He's missed football camps in Boulder this summer amid reports that he's been ill.
On Sunday, the production crew of 'Well Off Media,' which chronicles Sanders and the Buffaloes, posted a video on YouTube of the coach's first meeting with the team. In the middle of the clip, there was a scene, dated May 9, where Sanders said: 'I don't know if I'm ready mentally, emotionally. Last night was tough, yesterday was tough, because I had to make a will. That's not easy at all, to think that you may not be here.'
Sanders has dealt with other health issues. Many of them have involved his left foot since having two toes amputated in 2021 because of blood clot issues while he was coaching at Jackson State. He missed media day in 2023, his inaugural year at Colorado, after a procedure to remove a blood clot from his right leg and another to straighten toes on his left foot.
In March, Sanders signed a contract extension through the 2029 season.
The Buffaloes kick off the season on Aug. 29 against Georgia Tech at Folsom Field. It will be the first season in quite some time that he hasn't coached one of his sons. Quarterback Shedeur Sanders was drafted by the Cleveland Browns while Shilo, a safety, is in camp with the Tampa Bay Buccaneers.
Deion Sanders and the Buffaloes went 4-8 in his first season and 9-4 last season, with an appearance in the Alamo Bowl. They have big shoes to fill in replacing Shedeur Sanders and Heisman Trophy winner Travis Hunter.
Pat Graham, The Associated Press
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBC
an hour ago
- CBC
Enhanced Games (no drug testing) signs its 1st female athlete, world champion swimmer Megan Romano
The Olympic-style sports venture that will run an event next year with no drug testing signed world-champion swimmer Megan Romano as its first female and first American athlete Friday. The Enhanced Games will debut next May in Las Vegas, featuring swimming, track and weightlifting competitions in an event that will allow athletes to use performance enhancers. Romano calls competing in the event "an opportunity to push the boundaries of human performance in a transparent and scientifically-backed environment, and to compete on a stage where female athletes are valued and compensated fairly. equally. I believe this is the future of sport." The Enhanced Games will offer a prize purse of $500,000 for each event with $1 million bonuses going to anyone who breaks a world record in the 100-metre sprint (track) and 50m freestyle (swimming). Those marks would not count as "official," because world records need to be ratified by international federations, which require record-breakers to pass doping tests. The International Olympic Committee has condemned the concept of the Enhanced Games, saying, "If you want to destroy any concept of fair play and fair competition in sport, this would be a good way to do it." But the games have built some momentum and raised money in the "double-digit millions," according to founder Aron D'Souza. Four male swimmers, including Olympic medalist James Magnussen of Australia, have committed to the games. Romano, a standout swimmer at Georgia in college, anchored the U.S. 4x100 freestyle relay team to a gold medal at world championships in 2013.
Globe and Mail
an hour ago
- Globe and Mail
Pfizer's Elranatamab Study: Continued Access for Multiple Myeloma Patients
Pfizer Inc ((PFE)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Pfizer Inc. is conducting an Elranatamab Post Trial Access Study for participants with Multiple Myeloma, officially titled 'ELRANATAMAB POST TRIAL ACCESS: AN OPEN-LABEL, SINGLE-ARM STUDY FOR PARTICIPANTS WITH MULTIPLE MYELOMA CONTINUING FROM PFIZER-SPONSORED ELRANATAMAB CLINICAL STUDIES'. The study aims to provide continued access to elranatamab for patients who have shown clinical benefit in previous trials. This is significant as it supports ongoing treatment for patients with limited options. The intervention being tested is Elranatamab, a drug designed as a heterodimeric humanized full-length bispecific IgG2 kappa antibody. It targets BCMA on Multiple Myeloma cells and CD3 on T cells, aiming to enhance the immune response against cancer cells. The study is designed as an open-label, single-arm trial with no masking, focusing on treatment. All participants receive Elranatamab until disease progression, unacceptable toxicity, withdrawal of consent, study termination, or commercial availability of the drug in their country. The study began on October 3, 2023, and is currently recruiting. The last update was submitted on July 28, 2025. These dates are crucial for tracking the study's progress and understanding its timeline. This update may positively influence Pfizer's stock performance by demonstrating continued commitment to innovative cancer treatments. It may also impact investor sentiment favorably, especially in the context of competitive advancements in cancer therapies. The study is ongoing, with further details available on the ClinicalTrials portal.
Globe and Mail
2 hours ago
- Globe and Mail
TruBridge Announces Second Quarter 2025 Conference Call to Be Held Friday, August 8, 2025
TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, today announced that it will release its financial results for the second quarter ended June 30, 2025, on Thursday, August 7, 2025, after the market closes. The Company will host a conference call at 7:30 a.m. Central Time, 8:30 a.m. Eastern Time on Friday, August 8, 2025. To access this interactive teleconference, dial (877) 407-0890 and request connection to the TruBridge earnings conference call. A live broadcast of TruBridge's conference call will also be available online at the Company's investor relations website, The 30-day online replay will be available approximately an hour following the conclusion of the live broadcast. About TruBridge TruBridge proudly supports rural and community hospitals and providers in their efforts to stay strong, independent, and deeply rooted in the communities they serve. Backed by more than 45 years of healthcare experience and trusted by over 1,500 clients nationwide, we offer a mix of technology, services, and strategic expertise — including revenue cycle management, electronic health records (EHR) and analytics — all designed singularly for the realities of rural and community healthcare. With a steadfast commitment to keeping care local, TruBridge helps hospitals flourish as the economic heart of their communities, delivering high-quality, personal care close to home. For more information, visit
